Scientists Discover Frog Gut Bacterium That Could Transform Future Cancer Treatments
A naturally occurring microbe found in amphibians shows promising tumour-fighting abilities in early research
Scientists have discovered a remarkable bacterium living inside the digestive systems of amphibians that may offer a new approach to fighting cancer. Researchers say the microbe, known as Ewingella americana, has shown powerful tumour-targeting abilities in laboratory studies and could become the foundation for future bacterial cancer therapies.
The discovery comes from researchers at the Japan Advanced Institute of Science and Technology, who investigated whether bacteria naturally found in amphibians could help attack cancer cells. Their findings suggest that one particular strain of Ewingella americana was able to eliminate bowel cancer tumours in mice after a single treatment.
Although the research is still at an early stage and has not yet been tested in humans, scientists believe the results provide important evidence that specially selected bacteria could one day become part of advanced cancer treatment strategies.
How the cancer-fighting bacterium was discovered
The research team collected 45 bacterial strains from the intestines of different amphibians and reptiles, including Japanese tree frogs, fire belly newts, and grass lizards. These microorganisms were then isolated and grown under laboratory conditions for further testing.
Among the collected strains, nine showed potential anti-cancer effects. However, Ewingella americana produced the strongest response against tumours.
In experiments involving mice with bowel cancer, researchers delivered the bacteria through an intravenous injection. The results were significant, with the treatment producing complete tumour elimination in the tested models.
Scientists described the bacterium as having “superior therapeutic efficacy” compared with some conventional cancer treatment approaches in the experimental setting.
A unique two-way attack against tumours
One of the most interesting aspects of the discovery is the way the bacterium appears to fight cancer. Researchers found that Ewingella americana works through two different mechanisms.
First, the bacterium directly attacks tumour cells. It can survive in environments with very low oxygen levels, which are commonly found inside solid tumours. This ability allows the bacteria to multiply within tumour areas and damage cancer cells directly.
Second, the bacterium activates the body's immune system. The presence of the microbe attracts immune cells, including T cells, B cells, and neutrophils, which then help target and destroy cancer tissue.
According to researchers, this combination of direct tumour destruction and immune activation makes the bacterium particularly interesting for future cancer therapy development.
Why bacteria may help treat cancer
The idea of using bacteria as medicine may sound unusual, but scientists have been studying bacterial cancer therapies for years. Some bacteria naturally move toward areas with poor oxygen supply, which are often found in solid tumours.
This natural ability gives certain microbes a potential advantage because they can reach cancer regions that are difficult for traditional treatments to access.
In this study, researchers observed that Ewingella americana increased its population inside tumours by around 3,000 times within 24 hours after injection. At the same time, the bacteria were found mainly inside tumour tissue rather than healthy organs.
The study reported that the bacteria were quickly removed from the bloodstream, with a half-life of about 1.2 hours. Researchers also found no evidence of infection in important organs such as the liver, lungs, kidneys, heart, and spleen.
Potential future applications
The findings represent a proof of concept rather than a ready-to-use treatment. Before bacterial therapies can be considered for human patients, scientists will need to conduct extensive safety testing and clinical trials.
Future research may explore whether similar bacterial approaches could work against other solid tumours, including breast cancer, pancreatic cancer, and melanoma.
Researchers believe that studying microorganisms from diverse environments, including amphibian ecosystems, could reveal new medical tools. The discovery highlights the importance of microbial biodiversity and how naturally occurring organisms may contribute to future healthcare innovations.
Challenges before human treatment becomes possible
Despite the promising results, several challenges remain. A treatment that works in mice does not always produce the same results in humans. Researchers must determine the correct dosage, safety profile, delivery method, and possible side effects before human trials can begin.
Scientists will also need to understand how the human immune system responds to the bacterium and whether the treatment can be controlled effectively.
Cancer is a complex disease, and future bacterial therapies would likely be developed as part of combination treatments alongside existing approaches such as chemotherapy, immunotherapy, radiation therapy, or targeted medicines.
A promising new direction in cancer research
The discovery of Ewingella americana highlights the growing interest in using nature as a source of medical breakthroughs. From plants and marine organisms to bacteria living inside animals, researchers continue to investigate how biological systems can provide new solutions for difficult diseases.
While the frog-associated bacterium is not yet a cancer cure, the early findings offer hope that carefully developed microbial therapies could expand the range of tools available to fight cancer in the future.
As research continues, scientists will focus on turning this promising laboratory discovery into a safe and effective treatment option for patients.
Sources
- Japan Advanced Institute of Science and Technology research team study on Ewingella americana bacterial cancer therapy.
- Journal: Gut Microbes, research article on naturally occurring bacterial therapeutics and tumour elimination.
- EurekAlert science news coverage of the amphibian gut bacterium cancer research.
Disclaimer
This article is for informational and educational purposes only. The research discussed was conducted in laboratory models, including mice, and does not represent an approved cancer treatment for humans. Patients should not change or delay medical treatments based on early scientific findings. Always consult qualified healthcare professionals for medical advice and cancer treatment decisions.